The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02594046 |
Recruitment Status :
Completed
First Posted : November 1, 2015
Last Update Posted : April 5, 2017
|
Sponsor:
Pusan National University Hospital
Information provided by (Responsible Party):
Sang Yeoup Lee, Pusan National University Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Androgenic Alopecia | Other: stem cell component extract | Not Applicable |
This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks. Hair count and thickness will be primary outcomes.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 38 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Participant, Care Provider, Investigator) |
Primary Purpose: | Supportive Care |
Official Title: | The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia |
Study Start Date : | July 1, 2015 |
Actual Primary Completion Date : | February 28, 2016 |
Actual Study Completion Date : | May 28, 2016 |
Resource links provided by the National Library of Medicine

Arm | Intervention/treatment |
---|---|
Experimental: stem cell group
stem cell group who apply 1.2 g of allogeneic human adipose derived stem cell component extract on their scalp for 16 weeks
|
Other: stem cell component extract
The Allogeneic Human adipose derived stem cell component extract
Other Name: Tiara hair toninc |
Placebo Comparator: placebo group
placebo group who apply a placebo on their scalp for 16 weeks
|
Other: stem cell component extract
The Allogeneic Human adipose derived stem cell component extract
Other Name: Tiara hair toninc |
Primary Outcome Measures :
- change of total hair counts by phototrichogram [ Time Frame: 16 weeks ]
Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 19 Years to 59 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- androgenic alopecia basic and specific(BASP) classification: M2, C2, U1, V1, or F1 or higher
Exclusion Criteria:
- patient of scalp disease
No Contacts or Locations Provided
Responsible Party: | Sang Yeoup Lee, professor, Pusan National University Hospital |
ClinicalTrials.gov Identifier: | NCT02594046 |
Other Study ID Numbers: |
L-2015-199-2 |
First Posted: | November 1, 2015 Key Record Dates |
Last Update Posted: | April 5, 2017 |
Last Verified: | April 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Additional relevant MeSH terms:
Alopecia Alopecia Areata Hypotrichosis |
Hair Diseases Skin Diseases Pathological Conditions, Anatomical |